Research
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318829/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409845/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384834/
https://jamanetwork.com/journals/jamaneurology/fullarticle/783630
https://pubmed.ncbi.nlm.nih.gov/33211912/
There are 7,000 rare diseases that affect millions of people. In the USAA disease is considered rare if fewer than 200,000 people are affected by it. Because these diseases are rare, a lot is still unknown. This creates problems in the management of rare diseases, like autoimmune encephalitis, because it leads to misdiagnosis, unmet treatment, […]
AEA Research Network Month is when the AE Alliance focuses on research funding, collaborations and AE research awareness. What’s our goal? What can you expect during May 2023? How can you ensure you don’t miss out? If you are on Facebook or Instagram, follow us! Not a social media person? Check our blog daily. We may not post everyday but […]
It was August 15, 2023 when we introduced Dr. Robin van Steenhoven. Click here for the introductory post where we learned about him, his study plans and how his project would help patients and families affected by AE. In the 2023 AEA Community Seed Grant Final Report, Dr. van Steenhoven explains the outcomes of his project, the Seronegative […]
Anti-N-methyl-D-aspartate receptor encephalitis: A targeted review of clinical presentation, diagnosis, and approaches to psychopharmacologic management Kruse et al Annals of Clinical Psychiatry. 2014 Feb;26(1):e1-9 https://www.researchgate.net/profile/Michael_Davis27/publication/260118368_Anti-N-methyl-D-aspartate_receptor_encephalitis_A_targeted_review_of_clinical_presentation_diagnosis_and_approaches_to_psychopharmacologic_management/links/559b423708ae5d8f39380611/Anti-N-methyl-D-aspartate-receptor-encephalitis-A-targeted-review-of-clinical-presentation-diagnosis-and-approaches-to-psychopharmacologic-management.pdf Anti-N-methyl-d-aspartate receptor encephalitis was formally described in 2007 and includes a range of psychiatric and neurologic symptoms. Most patients with anti-NMDAR encephalitis initially present to psychiatrists for diagnosis and treatment. […]
Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A new challenging entity for consultation-liaison psychiatrist Maccaferri et al Brain Disord Ther 2016 May; 5(2):215 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959779/ Anti-N-methyl-D-aspartate receptor encephalitis is a relatively newly identified autoimmune neuropsychiatric disorder that predominantly affects children and young adults. Although psychiatric symptoms are highly prevalent and frequently severe, it has mainly been reported in neurological, but […]